The Community Guide

- gsearch

Search Results

Narrow Results:

2024 65
2023 66
2022 144
2021 449
2020 567

1 - 20 of 1291 Results

Refine Results

Refine Results:

FAQ : CDC distribution of COVID-19 assays

CITE Title : FAQ : CDC distribution of COVID-19 assays Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases Published Date : Oct. 6, 2021 URL : https://stacks.cdc.gov/view/cdc/110524 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases (2021). FAQ : CDC distribution of COVID-19 assays. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases "FAQ : CDC distribution of COVID-19 assays" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases "FAQ : CDC distribution of COVID-19 assays" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases

Oct. 6, 2021

:

Updated Oct. 6, 2021
Requirement for proof of negative COVID-19 test or documentation of recovery from COVID-19 : required for all air passengers two years of age or older boarding a flight from a foreign country to the United States

CITE Title : Requirement for proof of negative COVID-19 test or documentation of recovery from COVID-19 : required for all air passengers two years of age or older boarding a flight from a foreign country to the United States Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Nov. 5, 2021 URL : https://stacks.cdc.gov/view/cdc/111370 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Requirement for proof of negative COVID-19 test or documentation of recovery from COVID-19 : required for all air passengers two years of age or older boarding a flight from a foreign country to the United States. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Requirement for proof of negative COVID-19 test or documentation of recovery from COVID-19 : required for all air passengers two years of age or older boarding a flight from a foreign country to the United States" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Requirement for proof of negative COVID-19 test or documentation of recovery from COVID-19 : required for all air passengers two years of age or older boarding a flight from a foreign country to the United States" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Nov. 5, 2021

:

Updated Nov. 5, 2021On October 25, 2021 CDC amended its January 25, 2021 Order, titled, “Requirement for Proof of Negative COVID-19 Test or Recovery...
TRAVELING TO THE UNITED STATES FROM A FOREIGN COUNTRY BY AIR

CITE Title : TRAVELING TO THE UNITED STATES FROM A FOREIGN COUNTRY BY AIR Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : Nov. 5, 2021 Pages in Document : 1 poster URL : https://stacks.cdc.gov/view/cdc/111369 Centers for Disease Control and Prevention (U.S.) (2021). TRAVELING TO THE UNITED STATES FROM A FOREIGN COUNTRY BY AIR. Centers for Disease Control and Prevention (U.S.) "TRAVELING TO THE UNITED STATES FROM A FOREIGN COUNTRY BY AIR" (2021) Centers for Disease Control and Prevention (U.S.) "TRAVELING TO THE UNITED STATES FROM A FOREIGN COUNTRY BY AIR" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

Nov. 5, 2021

:

CS327569-DPublication date from document properties.requirements-travel-to-us-by-air-quick-reference-p.pdf
Interim guidance for SARS-CoV-2 testing in non-healthcare workplaces

CITE Title : Interim guidance for SARS-CoV-2 testing in non-healthcare workplaces Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Oct. 7, 2021 URL : https://stacks.cdc.gov/view/cdc/110529 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Interim guidance for SARS-CoV-2 testing in non-healthcare workplaces. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidance for SARS-CoV-2 testing in non-healthcare workplaces" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidance for SARS-CoV-2 testing in non-healthcare workplaces" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Oct. 7, 2021

:

Updated Oct. 7, 2021
Test for current infection

CITE Title : Test for current infection Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Oct. 27, 2021 URL : https://stacks.cdc.gov/view/cdc/111049 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Test for current infection. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Test for current infection" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Test for current infection" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Oct. 27, 2021

:

Updated Oct. 27, 2021A viral test checks specimens from your nose or your mouth to find out if you are currently infected with the virus that causes C...
COVID-19 testing overview

CITE Title : COVID-19 testing overview Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Oct. 27, 2021 URL : https://stacks.cdc.gov/view/cdc/111048 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). COVID-19 testing overview. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "COVID-19 testing overview" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "COVID-19 testing overview" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Oct. 27, 2021

:

Updated Oct. 27, 2021
COVID-19 testing overview

CITE Title : COVID-19 testing overview Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Oct. 21, 2021 URL : https://stacks.cdc.gov/view/cdc/110983 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). COVID-19 testing overview. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "COVID-19 testing overview" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "COVID-19 testing overview" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Oct. 21, 2021

:

Updated Oct. 21, 2021
Requirement for proof of negative COVID-19 test or documentation of recovery from COVID-19 : required for all air passengers two years of age or older boarding a flight from a foreign country to the United States

CITE Title : Requirement for proof of negative COVID-19 test or documentation of recovery from COVID-19 : required for all air passengers two years of age or older boarding a flight from a foreign country to the United States Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Oct. 25, 2021 URL : https://stacks.cdc.gov/view/cdc/111017 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Requirement for proof of negative COVID-19 test or documentation of recovery from COVID-19 : required for all air passengers two years of age or older boarding a flight from a foreign country to the United States. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Requirement for proof of negative COVID-19 test or documentation of recovery from COVID-19 : required for all air passengers two years of age or older boarding a flight from a foreign country to the United States" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Requirement for proof of negative COVID-19 test or documentation of recovery from COVID-19 : required for all air passengers two years of age or older boarding a flight from a foreign country to the United States" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Oct. 25, 2021

No Description
Standard operating procedure (SOP) for triage of suspected COVID-19 patients in non-US healthcare settings : early identification and prevention of transmission during triage

CITE Title : Standard operating procedure (SOP) for triage of suspected COVID-19 patients in non-US healthcare settings : early identification and prevention of transmission during triage Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Oct. 18, 2021 URL : https://stacks.cdc.gov/view/cdc/110818 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Standard operating procedure (SOP) for triage of suspected COVID-19 patients in non-US healthcare settings : early identification and prevention of transmission during triage. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Standard operating procedure (SOP) for triage of suspected COVID-19 patients in non-US healthcare settings : early identification and prevention of transmission during triage" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Standard operating procedure (SOP) for triage of suspected COVID-19 patients in non-US healthcare settings : early identification and prevention of transmission during triage" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Oct. 18, 2021

:

Updated Oct. 18, 2021This document is intended for healthcare facilities that are receiving or are preparing to receive patients with suspected or con...
What your test results mean

CITE Title : What your test results mean Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 09/28/2021 Pages in Document : 1 poster URL : https://stacks.cdc.gov/view/cdc/110655 Centers for Disease Control and Prevention (U.S.) (2021). What your test results mean. Centers for Disease Control and Prevention (U.S.) "What your test results mean" (2021) Centers for Disease Control and Prevention (U.S.) "What your test results mean" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

09/28/2021

:

Accessible version available at https://www.cdc.gov/coronavirus/2019-ncov/testing/diagnostic-testing.html17369-F | 09/28/2021What-Your-Test-Results-Me...
Cómo recolectar una muestra de la región nasal anterior para la prueba de COVID-19

CITE Title : Cómo recolectar una muestra de la región nasal anterior para la prueba de COVID-19 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 02/09/2021 URL : https://stacks.cdc.gov/view/cdc/104216 Centers for Disease Control and Prevention (U.S.) (2021). Cómo recolectar una muestra de la región nasal anterior para la prueba de COVID-19. Centers for Disease Control and Prevention (U.S.) "Cómo recolectar una muestra de la región nasal anterior para la prueba de COVID-19" (2021) Centers for Disease Control and Prevention (U.S.) "Cómo recolectar una muestra de la región nasal anterior para la prueba de COVID-19" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

02/09/2021

:

Use solamente un kit de recolección de muestras autorizado, provisto por su proveedor de atención médica o el personal del lugar donde realicen ...
How to collect an anterior nasal swab specimen for COVID-19 testing

CITE Title : How to collect an anterior nasal swab specimen for COVID-19 testing Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 02/04/2021 URL : https://stacks.cdc.gov/view/cdc/104217 Centers for Disease Control and Prevention (U.S.) (2021). How to collect an anterior nasal swab specimen for COVID-19 testing. Centers for Disease Control and Prevention (U.S.) "How to collect an anterior nasal swab specimen for COVID-19 testing" (2021) Centers for Disease Control and Prevention (U.S.) "How to collect an anterior nasal swab specimen for COVID-19 testing" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

02/04/2021

:

Use only an authorized specimen collection kit given to you by your healthcare provider or personnel at the testing center, or purchased over the coun...
COVID-19 testing overview

CITE Title : COVID-19 testing overview Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Mar 17, 2021 URL : https://stacks.cdc.gov/view/cdc/104218 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). COVID-19 testing overview. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "COVID-19 testing overview" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "COVID-19 testing overview" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Mar 17, 2021

:

Updated Mar. 17, 2021
United States laboratory testing : Cumulative COVID-19 Viral (RT-PCR) Laboratory Tests Performed per 100k by State/Territory

CITE Title : United States laboratory testing : Cumulative COVID-19 Viral (RT-PCR) Laboratory Tests Performed per 100k by State/Territory Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : March 9, 2021 Source : CDC COVID Data Tracker URL : https://stacks.cdc.gov/view/cdc/103936 Centers for Disease Control and Prevention (U.S.) (2021). United States laboratory testing : Cumulative COVID-19 Viral (RT-PCR) Laboratory Tests Performed per 100k by State/Territory. Centers for Disease Control and Prevention (U.S.) "United States laboratory testing : Cumulative COVID-19 Viral (RT-PCR) Laboratory Tests Performed per 100k by State/Territory" (2021) Centers for Disease Control and Prevention (U.S.) "United States laboratory testing : Cumulative COVID-19 Viral (RT-PCR) Laboratory Tests Performed per 100k by State/Territory" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

March 9, 2021 | CDC COVID Data Tracker

:

CDC | Updated: Mar 09 2021
United States laboratory testing : Cumulative COVID-19 Viral (RT-PCR) Laboratory Tests Performed by State/Territory

CITE Title : United States laboratory testing : Cumulative COVID-19 Viral (RT-PCR) Laboratory Tests Performed by State/Territory Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : March 9, 2021 Source : CDC COVID Data Tracker URL : https://stacks.cdc.gov/view/cdc/103935 Centers for Disease Control and Prevention (U.S.) (2021). United States laboratory testing : Cumulative COVID-19 Viral (RT-PCR) Laboratory Tests Performed by State/Territory. Centers for Disease Control and Prevention (U.S.) "United States laboratory testing : Cumulative COVID-19 Viral (RT-PCR) Laboratory Tests Performed by State/Territory" (2021) Centers for Disease Control and Prevention (U.S.) "United States laboratory testing : Cumulative COVID-19 Viral (RT-PCR) Laboratory Tests Performed by State/Territory" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

March 9, 2021 | CDC COVID Data Tracker

:

CDC | Updated: Mar 09 2021
United States laboratory testing : COVID-19 Viral (RT-PCR) Laboratory Tests Performed in Last 30 Days by State/Territory

CITE Title : United States laboratory testing : COVID-19 Viral (RT-PCR) Laboratory Tests Performed in Last 30 Days by State/Territory Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : March 9, 2021 Source : CDC COVID Data Tracker URL : https://stacks.cdc.gov/view/cdc/103934 Centers for Disease Control and Prevention (U.S.) (2021). United States laboratory testing : COVID-19 Viral (RT-PCR) Laboratory Tests Performed in Last 30 Days by State/Territory. Centers for Disease Control and Prevention (U.S.) "United States laboratory testing : COVID-19 Viral (RT-PCR) Laboratory Tests Performed in Last 30 Days by State/Territory" (2021) Centers for Disease Control and Prevention (U.S.) "United States laboratory testing : COVID-19 Viral (RT-PCR) Laboratory Tests Performed in Last 30 Days by State/Territory" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

March 9, 2021 | CDC COVID Data Tracker

:

CDC | Updated: Mar 09 2021
United States laboratory testing : COVID-19 Viral (RT-PCR) Laboratory Tests Performed in Last 7 Days by State/Territory

CITE Title : United States laboratory testing : COVID-19 Viral (RT-PCR) Laboratory Tests Performed in Last 7 Days by State/Territory Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : March 9, 2021 Source : CDC COVID Data Tracker URL : https://stacks.cdc.gov/view/cdc/103933 Centers for Disease Control and Prevention (U.S.) (2021). United States laboratory testing : COVID-19 Viral (RT-PCR) Laboratory Tests Performed in Last 7 Days by State/Territory. Centers for Disease Control and Prevention (U.S.) "United States laboratory testing : COVID-19 Viral (RT-PCR) Laboratory Tests Performed in Last 7 Days by State/Territory" (2021) Centers for Disease Control and Prevention (U.S.) "United States laboratory testing : COVID-19 Viral (RT-PCR) Laboratory Tests Performed in Last 7 Days by State/Territory" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

March 9, 2021 | CDC COVID Data Tracker

:

CDC | Updated: Mar 09 2021
United States laboratory testing : COVID-19 Viral (RT-PCR) Laboratory Test 7-day Percent Positivity by State/Territory

CITE Title : United States laboratory testing : COVID-19 Viral (RT-PCR) Laboratory Test 7-day Percent Positivity by State/Territory Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : March 9, 2021 Source : CDC COVID Data Tracker URL : https://stacks.cdc.gov/view/cdc/103937 Centers for Disease Control and Prevention (U.S.) (2021). United States laboratory testing : COVID-19 Viral (RT-PCR) Laboratory Test 7-day Percent Positivity by State/Territory. Centers for Disease Control and Prevention (U.S.) "United States laboratory testing : COVID-19 Viral (RT-PCR) Laboratory Test 7-day Percent Positivity by State/Territory" (2021) Centers for Disease Control and Prevention (U.S.) "United States laboratory testing : COVID-19 Viral (RT-PCR) Laboratory Test 7-day Percent Positivity by State/Territory" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

March 9, 2021 | CDC COVID Data Tracker

:

CDC | Updated: Mar 09 2021
The Role of Testing in Reducing SARS-CoV-2 Transmission on College Campuses

CITE Title : The Role of Testing in Reducing SARS-CoV-2 Transmission on College Campuses Personal Author(s) : Barrios, Lisa C.;Green, Ridgely Fisk;Honein, Margaret A.; Published Date : January 2021 Source : J Adolesc Health. 68(1):1-2 URL : https://stacks.cdc.gov/view/cdc/100846 Barrios, Lisa C. et al. (2021). The Role of Testing in Reducing SARS-CoV-2 Transmission on College Campuses. 68(1). Barrios, Lisa C. and Green, Ridgely Fisk and Honein, Margaret A. "The Role of Testing in Reducing SARS-CoV-2 Transmission on College Campuses" 68, no. 1 (2021) Barrios, Lisa C. et al. "The Role of Testing in Reducing SARS-CoV-2 Transmission on College Campuses" vol. 68, no. 1, 2021 Export RIS Citation Information.

:

Barrios, Lisa C. ;

Green, Ridgely Fisk

January 2021 | J Adolesc Health. 68(1):1-2

No Description
Testing strategies for SARS-CoV-2

CITE Title : Testing strategies for SARS-CoV-2 Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Mar 11, 2021 URL : https://stacks.cdc.gov/view/cdc/104086 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Testing strategies for SARS-CoV-2. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Testing strategies for SARS-CoV-2" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Testing strategies for SARS-CoV-2" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Mar 11, 2021

:

Updated Mar. 11, 2021Diagnostic testing is intended to identify current infection in individuals and is performed when a person has signs or symptoms ...

1 - 20 / 1291

1 2 3 4 ... 65